Yang Xiang to Neoplasms
This is a "connection" page, showing publications Yang Xiang has written about Neoplasms.
Connection Strength
0.947
-
Chen L, Huang L, Gu Y, Li C, Sun P, Xiang Y. Novel post-translational modifications of protein by metabolites with immune responses and immune-related molecules in cancer immunotherapy. Int J Biol Macromol. 2024 Oct; 277(Pt 1):133883.
Score: 0.408
-
Lan XQ, Deng CJ, Wang QQ, Zhao LM, Jiao BW, Xiang Y. The role of TGF-? signaling in muscle atrophy, sarcopenia and cancer cachexia. Gen Comp Endocrinol. 2024 07 01; 353:114513.
Score: 0.401
-
Gao Y, Du C, Xu Y, Cheng X, Zhao H, Jiang F, Cheng N, Xiang Y, Zhang Y, Li Y, Liu H, Chai X, Lian X, Zhao W, Li N. Optimal Levothyroxine Dosing Strategy for Immune Checkpoint Inhibitor-related Hypothyroidism: A Retrospective Study. J Clin Endocrinol Metab. 2025 Nov 18; 110(12):3342-3353.
Score: 0.112
-
Zhang Y, Deng X, Xia L, Liang J, Chen M, Xu X, Chen W, Ding J, Yu C, Liu L, Xiang Y, Lin Y, Duan F, Feng W, Chen Y, Gao X. Living Therapeutics for Synergistic Hydrogen-Photothermal Cancer Treatment by Photosynthetic Bacteria. Adv Sci (Weinh). 2025 01; 12(1):e2408807.
Score: 0.026